Basit öğe kaydını göster

IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis

dc.contributor.authorZeft, Andrew S.
dc.contributor.authorArthur, Victoria L.
dc.contributor.authorShuldiner, Emily
dc.contributor.authorRemmers, Elaine F.
dc.contributor.authorHinks, Anne
dc.contributor.authorGrom, Alexei A.
dc.contributor.authorMartini, Alberto
dc.contributor.authorGattorno, Marco
dc.contributor.authorÖZEN, SEZA
dc.contributor.authorPrahalad, Sampath
dc.contributor.authorBohnsack, John F.
dc.contributor.authorIlowite, Norman T.
dc.contributor.authorMellins, Elizabeth D.
dc.contributor.authorRusso, Ricardo
dc.contributor.authorLen, Claudio
dc.contributor.authorOliveira, Sheila
dc.contributor.authorYeung, Rae S. M.
dc.contributor.authorRosenberg, Alan M.
dc.contributor.authorWedderburn, Lucy R.
dc.contributor.authorAnton, Jordi
dc.contributor.authorHaas, Johannes-Peter
dc.contributor.authorRoesen-Wolff, Angela
dc.contributor.authorMinden, Kirsten
dc.contributor.authorSzymanski, Ann Marie
dc.contributor.authorThomson, Wendy
dc.contributor.authorKastner, Daniel L.
dc.contributor.authorWoo, Patricia
dc.contributor.authorOmbrello, Michael J.
dc.contributor.authorFoell, Dirk
dc.date.accessioned2022-02-18T09:34:39Z
dc.date.available2022-02-18T09:34:39Z
dc.date.issued2018
dc.identifier.citationArthur V. L. , Shuldiner E., Remmers E. F. , Hinks A., Grom A. A. , Foell D., Martini A., Gattorno M., ÖZEN S., Prahalad S., et al., "IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis", ARTHRITIS & RHEUMATOLOGY, cilt.70, sa.8, ss.1319-1330, 2018
dc.identifier.issn2326-5191
dc.identifier.otherav_48108222-c741-4d0a-8252-dca038341a9a
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/177484
dc.identifier.urihttps://doi.org/10.1002/art.40498
dc.description.abstractObjective. To determine whether systemic juvenile idiopathic arthritis (JIA) susceptibility loci that were identified by candidate gene studies demonstrate association with systemic JIA in the largest study population assembled to date.
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectRheumatology
dc.subjectHealth Sciences
dc.titleIL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis
dc.typeMakale
dc.relation.journalARTHRITIS & RHEUMATOLOGY
dc.contributor.departmentNIAMSD , ,
dc.identifier.volume70
dc.identifier.issue8
dc.identifier.startpage1319
dc.identifier.endpage1330
dc.contributor.firstauthorID3142044


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster